More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the presentation of additional data ...
Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...
Maldives achieves historic milestone in eliminating mother-to-child transmission of HIV, syphilis, and Hepatitis B, setting ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the ...
Merck & Co has presented additional data from Phase III studies of the investigational, once-daily, oral, two-drug regimen of ...
The Yolo County Health and Human Services Agency now offers expanded access to medications that prevent human immunodeficiency virus through the California Department of Public Health’s Pre-Exposure P ...
Young women are contracting HIV faster than anyone else in South Africa, with about four out of every 10 new infections coming from just this group, even though they make up only about 8% of the total ...
Merck (MRK), known as MSD outside of the U.S. and Canada, announced the presentation of additional data from the Phase 3 studies of the ...
China NMPA approves GSK’s Shingrix for prevention of shingles in adults aged 18 and over who are at increased risk due to immunodeficiency or immunosuppression: London, UK Wedne ...